Corvus Pharmaceuticals, Inc. — Director's Dealing 2017

Jun 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2017-06-23

Reporting Person: Novo Holdings A/S (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-23	COMMON STOCK	P	20000	$10.95	Acquired	3244046	Direct